| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |





From the Departments of Clinical Chemistry and
Pathobiochemistry,*
Internal Medicine
I,
and General
Surgery,
University Hospital, Ulm, Germany
| Abstract |
|---|
|
|
|---|
-1)-mRNA and fibronectin-mRNA in PSC
10 hours after addition of the acidified macrophage supernatants. Cell
proliferation measured by bromodeoxyuridine incorporation was not
influenced by the macrophage supernatants. Unstimulated macrophages
released 1.97 pg TGFß1/µg of DNA over 24 hours and
lipopolysaccharide-activated macrophages released 6.61pg
TGFß1/µg of DNA over 24 hours. These data together with the
results that, in particular, transiently acidified
macrophage supernatants increased matrix synthesis, identify
TGFß as the responsible mediator. In conclusion, our data
demonstrate a paracrine stimulation of matrix synthesis of pancreatic
stellate cells via TGFß1 released by activated macrophages. We
suggest that macrophages might play a pivotal role in the development
of pancreas fibrosis.
| Introduction |
|---|
|
|
|---|
-actin, and
increased synthesis of collagen types I and III and
fibronectin.11
Pancreas fibrosis is commonly associated with chronic
inflammation.4
In chronic pancreatitis and in pancreas
carcinoma, infiltrating mononuclear cells13
might
potentiate fibrogenesis by the release of cytokines stimulating stromal
cells14
and by their cytotoxic effects.15
The
decreased intestinal motility during pancreatitis causes a bacterial
translocation to the peritoneal fluid, lymph, blood, liver, and
pancreas.16
Bacterial lipopolysaccharides (LPS) and the
LPS-binding protein form a complex that binds to the surface receptor
CD14 of the invaded monocytes, triggering the cells to become
activated.17,18
LPS activation of monocytes/macrophages
and aggregating platelets in areas of inflammation release several
polypeptide growth factors including TGFß, TGF
/EGF, basic
fibroblast growth factor (bFGF), and platelet-derived growth
factor (PDGF).19-22
It is suggested that these
factors are responsible for stimulating ECM synthesis and proliferation
of PSC.
Because macrophages are located close to PSC,11 their capacity to release TGFß is of particular interest. Recent investigations revealed that TGFß is a multifunctional regulator of cell growth and differentiation.23 TGFß stimulates the synthesis of ECM components and inhibits matrix degradation.24 TGFß is secreted as a latent form associated with a latency-associated peptid. Latent TGFß-binding protein (LTBP) is covalently bound to the latency-associated peptid and forms a high-molecular-weight complex termed latent TGFß complex.25 LTBP is assumed to play a strategic role in the assembly, secretion, and activation of latent TGFß.26 In chronic pancreatitis, the TGFß precursor was detected mainly in mononuclear cells located in fibrotic areas.27 LTBP is also predominantly present in mononuclear cells and in the ECM around them. The presence of both pro-TGFß and LTBP in monocytes and/or macrophages in areas of fibrosis strongly suggests that this cytokine is involved in the pathophysiology of chronic pancreatitis.27
In the present study, we demonstrate that transiently acidified supernatants of LPS stimulated human monocyte-derived macrophages contain TGFß and stimulated the synthesis of fibronectin and collagen type I in cultured PSCs. These findings suggest that activated macrophages play a critical role in pancreas fibrogenesis by stimulating matrix synthesis of PSCs in a paracrine way.
| Materials and Methods |
|---|
|
|
|---|
Materials were purchased from the following sources: Ficoll-Paque
from Pharmacia, Biotech (Uppsala, Sweden); biotin labeled CD14(My4) and
CD3-ECD from Coulter Immunotech (Hamburg, Germany); rabbit anti-human
collagen type I and biotin-labeled goat anti-human collagen type III
from Chemicon (Temecula, CA); rabbit anti-fibronectin from Behring
Diagnostics (Marburg, Germany); biotin labeled anti-rabbit, biotin
labeled anti-mouse, HRP anti-rabbit, biotin labeled anti-goat, HRP
anti-mouse, fluorescein-conjugated streptavidin, HRP-conjugated
streptavidin, mouse anti-BrdU, anti-CD19-PECy5, and anti-CD14-PE from
DAKO (Hamburg, Germany); streptavidin-Red 613 from Gibco BRL
(Eggenstein, Germany); mouse anti-
-smooth-muscle actin,
bromodeoxyuridine, and the High Pure RNA Extraction Kit from Boehringer
Mannheim (Mannheim, Germany); TSA Indirect from NEN Life Science
Products (Boston, MA); fluorescein-conjugated Escherichia
coli and propidium jodide (Orpegen, Heidelberg, Germany); trypan
blue, bisbenzimide, calf thymus DNA, yeast t-RNA,
diethylendtriaminepentaacetic (DTPA), monoclonal anti-fibronectin, and
ß-aminopropionitrile from Sigma (Deisenhofen, Germany); ascorbic acid
from Merck (Darmstadt, Germany); enhancement solution and
europium-conjugated streptavidin from Wallac Oy (Turku, Finland); and
TGFß1-sR-II/Fc chimera and biotinylated anti-human TGFß1 from R&D
Systems (Minneapolis, MN). The 18S rRNA probe was generously provided
by Dr. T. M. Gress (University Ulm, Germany). Ninety-six-well
microtiter plates (Maxi Sorp) were from Nunc GmbH (Wiesbaden, Germany),
cell culture plates and flasks were from Falcon (Becton Dickinson,
Heidelberg, Germany) and petriPerm was from In Vitro Systems
+ Services (Osterode, Germany). Hybond-N membranes were
purchased from Amersham-Buchler (Braunschweig, Germany).
Monocyte Isolation and Culture
Peripheral blood mononuclear cells were isolated from buffy coats of different donors by Ficoll-Paque gradient centrifugation. The mononuclear fraction was washed in PBS and then resuspended in RPMI 1640 containing 1% L-glutamine, 100 IU/ml penicillin, 100 µg/ml streptomycin and 10% fetal calf serum (FCS). Aliquots of the cell suspension (5 x 106 mononuclear cells/ml) were allowed to adhere in 75 cm2 tissue culture flasks in 37°C in a humidified 5% CO2 environment. For immunofluorescence staining cells were seeded on glass coverslips (1 cm2) in 6-well plates. To harvest cells for flow cytometric analysis, cells were seeded on petriPerm. After 2 hours the nonadherent cells were removed and fresh medium was added. Medium was changed each third day and cells were cultured for up to 14 days.
Production of Conditioned Media
Cultured macrophages in 75-cm2 flasks (1014 days after seeding) were washed with RPMI 1640. Thereafter 10 ml fresh RPMI per flask (with antibiotics, without FCS) was added and conditioned for 24 hours in the absence and presence of 8 µg/ml LPS. Conditioned media were removed under sterile conditions, centrifuged (800 rpm, 5 minutes, 4°C) to remove cell debris, and stored at -80°C. The media were dialyzed for 36 hours against 100 vol distilled water at 4°C in tubings (ZelluTrans, Roth, Karlsruhe, Germany) with 3.5-kd molecular cutoff. Thereafter media were concentrated 10-fold by lyophilization and sterilized by passing through a 0.22-µm pore size filter (Millex-GS, Millipore). To activate latent TGFß1, aliquots of the media were acidified with 1 mol/L HCl for 10 minutes, then neutralized by adding 1.2 N NaOH/0.5 mol/L Hepes.
Pancreatic Stellate Cell Isolation and Culture
Human pancreatic stellate cells were isolated by outgrowth, using explant techniques from histologically fibrotic areas of the pancreas surgically resected from patients with chronic pancreatitis. Small tissue blocks were cut (0.51 mm3) and seeded in 10-cm2 uncoated culture wells (6 per plate, 35 pieces/well) in the presence of 10 to 20% FCS in a 1:1 (v:v) mixture of Dulbeccos modified Eagles medium (DMEM) with Hams F12 medium. L-glutamine (2 mmol/L), penicillin/streptomycin, and amphotericine were freshly added. Tissue blocks were cultured at 37°C in a 5% CO2-air humidified atmosphere. Eighteen hours after seeding, culture medium was changed and 24 hours later the small tissue blocks were transferred to new culture plates. The pancreatic stellate cells grew out in high number and purity from the tissue blocks 1 to 3 days later. The small tissue blocks were removed after 2 to 3 weeks.
To obtain a higher number of cells with the inactivated resting fat storing phenotype, the cells were isolated by density gradient centrifugation from the pancreas of untreated male Wistar rats as described.11 Briefly, after the animals were anesthetized with pentobarbital, the abdomen was opened, the common bile duct was ligated, and a cannula was inserted into the biliopancreatic duct. The rats were exsanguinated and collagenase-containing Eagles medium (1 mg/5 ml) was instilled intraductally. The distended pancreas was removed and shaken in an Erlenmeyer flask (37°C, 15 minutes.). After this first digestion the pancreas was minced, followed by a second digestion with collagenase (1.75 mg/5 ml, 45 minutes.). Dispersion was accomplished by up-and-down suction through cannulas with decreasing diameters. After dissociation the acini and cells were filtered through a 250-µm nylon cloth and centrifuged after layering the filtrate on top of a dextran-Eagle-HEPES density gradient. Once centrifuged, cells were collected from the top of the gradient, washed twice, resuspended in Tris-buffered saline, and transferred on top of a Iodixanol (OptiPrep) density gradient. After another centrifugation, cells were collected from the top of the gradient, washed, and suspended in DMEM with 10% FCS, antibiotics, amphotericine, and L-glutamine. Thereafter cells were seeded in a density of 4 x 104 cells/cm2.
Cells were cultured at 37°C in a 5% CO2 humidified atmosphere. The medium consisted of DMEM/Hams F12 (1:1, v:v) with 10% FCS, 2% L-glutamine, 100 IU/ml penicillin, 100 µg/ml streptomycin, and 1% amphotericine. Medium was changed 3 times a week. After reaching confluency, cells were subcultured by trypsinization using a 0.025% trypsin solution containing 0.01% EDTA in phospate-buffered saline. Once the cell numbers were counted, they were again suspended in a complete medium and seeded with a density of 35 x 104 cells/cm2. To increase the cell number to obtain sufficient amounts of RNA, cells were seeded in 75-cm2 culture flasks (25 ml medium/flask).
Stimulation of Pancreatic Stellate Cells with Media Conditioned by Macrophages
Experiments were performed using PSC between passage 38. After passage PSC were cultured for 2 to 3 days in DMEM/HAMs F12 (1/1, v/v) in the presence of 10% FCS. Twelve hours before addition of macrophage supernatants, medium was changed to DMEM/HAMs F12 with 0.1% FCS. To study cell proliferation and matrix synthesis PSC were cultured in 24-well plates (2 cm2/well, 1 ml medium). To study matrix synthesis, native and transiently acidified macrophage supernatants (40 and 160 µl/ml) were added and cultures were stopped 24 hours later. To study cell proliferation BrdU (final concentration 0.5 x 10-5 M) was added 6 hours after addition of 40 µl/ml native and transiently acidified macrophage supernatants. Cultures were stopped 18 hours later. To perform immunofluorescence microscopy of collagen and fibronectin, PSC were seeded on 1-cm2 glass coverslips in 6-well plates and incubated with 40 µl/ml transiently acidified macrophage supernatant. Cultures were stopped 38 hours later. To isolate mRNA, PSCs were grown in 75 cm2 flasks containing 10 ml medium. To subconfluent quiescent cells (cultured for 12 hours in the presence of 0.1% FCS) 40µl/ml transiently acidified macrophage supernatant was added and cultures were stopped 10 hours later.
In all experiments the baseline (negative) control represents PSC cultured in DMEM/HAMs F12 with 0.1% FCS.
Immunfluorescence Microscopy and Flow Cytometric Analysis
Glass coverslips with cultured hPSC were washed in PBS to remove
medium proteins, fixed for 30 minutes in -20°C acetone, and blocked
with TNB for 45 minutes. For collagen type I the staining sequence was
primary antibody (rabbit-anti-human-collagen I, 1:100), second antibody
(HRP-anti-rabbit, 1:100), biotin-TSA-reagent (1:40) and
streptavidin-FITC (1:100). For collagen type III the staining sequence
was primary antibody (biotin labeled goat-anti-human-collagen III,
1:100), HRP-streptavidin (1:100), biotin-TSA-reagent (1:40) and
streptavidin-FITC (1:100). The staining sequence for fibronectin was
primary antibody (rabbit-anti-fibronectin, 1:100), second antibody
(biotin-anti-rabbit, 1:100) and streptavidin-FITC (1:100). For
-smooth muscle actin the staining sequence was primary antibody
(mouse anti-
-smooth muscle actin, 1:50), second antibody
(HRP-anti-mouse, 1:50), biotin-TSA-reagent (1:40) and streptavidin-FITC
(1:100). Cells were viewed by epifluorescence microscopy (Carl
Zeiss, Oberkochen, Germany) with appropriate filter sets.
To demonstrate phagocytosis macrophages were incubated with 3 x 107 opsonized FITC-conjugated E. coli for 6 hours at 37°C, washed with PBS, incubated first with biotin-anti-CD14 (1:33) and then with streptavidin-Red 613 (1:100). Thereafter, cells were fixed for 30 minutes in 4% formaldehyde. DNA was counterstained with bisbenzimide. Viability of cultured macrophages was assessed by trypan blue exclusion.
To analyze the cells by flow cytometry, macrophages were grown in petriPerm for 10 to 14 days and harvested by scraping. Thereafter cells were washed with PBS, resuspended, and analyzed for expression of CD14, CD3, and CD19 using an EPICS XL flow cytometer (Coulter Immunotech, Hamburg, Germany). Viable cells were detected by propidium jodide exclusion.
Quantitative Determination of Extracellular Matrix Synthesis
To measure collagen type I cells were cultured in DMEM/HAMs F12 with 0.1% FCS in the presence of ascorbic acid (100 µg/ml) and ß-aminopropionitrile (100 µg/ml). By time-resolved fluorescence-immunoassay collagen type I was measured in culture supernatants 24 hours after stimulation. Briefly, 100 µl cell culture supernatant (diluted 1:4 with 0.05 mol/L NaHCO3, pH 9.1) were transferred to 96-well microtiter plates (Nunc-Maxi Sorp) and incubated overnight at 4°C. After 3 washing steps (wash buffer: Tris 0.05 mol/l, NaCl 0.15 mol/l, Tween 20 0.05%, pH 7.5) plates were blocked during 2 hours with assay buffer (Tris 0.05 mol/l, NaCl 0.15 mol/l, dry milk powder 5%, pH 7.5). Thereafter, the plates were incubated for 3 hours with a polyclonal rabbit-anti-human-collagen type I (diluted 1:500 in assay buffer). After washing 3 times the plates were incubated for 2 hours with the second antibody (biotin-labeled anti-rabbit IgG diluted 1:1000 in assay buffer). Thereafter, an Europium-labeled streptavidin (diluted 1:1000 in assay buffer) was added and incubated for 1 hour. After additional 3 washing steps, 100 µl enhancement solution was added for 30 minutes at room temperature and thereafter time-resolved fluorescence of the Europium chelate was measured using a Victor 1420 Multilabel Counter (Fa. Wallac, Turku, Finland). All measurements were done in duplicate.
To measure c-fibronectin, time-resolved fluorescence immunoassay was used. Briefly, 96-well microtiter plates were coated 3 hours at room temperature with gelatin (10 µg/ml) in coating buffer (0.05 mol/L NaHCO3, pH 9.1) and thereafter blocked overnight at 4°C using assay buffer (Tris 0.05 mol/L, NaCl 0.15 mol/L, RIA grade albumin 0.5%, pH 7.7). Standards (100 µl, 500019 ng/ml) and culture supernatants diluted in assay buffer were added and incubated overnight at room temperature. Thereafter, the plates were incubated for 1 hour with a monoclonal mouse-anti-c-fibronectin diluted 1:1000 in assay buffer. After washing 3 times the plates were incubated for 1 hour with the second antibody (biotin-labeled anti-mouse IgG diluted 1:1000 in assay buffer) followed by 3 washing steps. Thereafter, an Europium-labeled strepavidin (diluted 1:1000 in assay buffer) was added and incubated for 1 hour. After 3 more washing steps, 100 µl enhancement solution was added for 30 minutes at room temperature and thereafter time-resolved fluorescence of the Europium chelate was measured using a Victor 1420 Multilabel Counter. All measurements were done in duplicate.
Quantitative Determination of TGFß
TGFß1 was measured by time-resolved fluorescence immunoassay. Ninety-six-well microtiter plates were coated overnight at room temperature with TGFß1-sR-II/Fc Chimera (0.2 µg/ml) diluted in coating buffer (0.05 mol/L NaHCO3, pH 9.2). After 3 washing steps (wash buffer: PBS, Tween 20 0.05%, pH 7.4), plates were blocked during 2 hours at room temperature with blocking buffer (PBS, Tween 20 5%, sucrose 5%, NaN3 0.05%) and again washed 3 times. One-hundred-microliter standards (5 ng/ml - 156 pg/ml) diluted in DMEM with 0.1% RIA grade albumin and culture supernatants diluted in diluent (PBS, milk powder 0.5%, Tween 20 0.05%) were added and incubated for 2 hours at room temperature. After 3 washing steps, plates were incubated with biotin anti-human TGBß1 diluted 1:250 in diluent (20 mmol/L Trizma-base, 150 mmol/L NaCl, 0.1% RIA grade albumin) for 2 hours, followed by 3 washing steps. Thereafter, an Europium-labeled streptavidin (diluted 1:1000 in diluent) was added and incubated for 1 hour. After additional 5 washing steps, 100 µl of enhancement solution were added for 30 minutes at room temperature and thereafter time-resolved fluorescence of the Europium chelate was measured using a Victor 1420 Multilabel Counter. All measurements were done in duplicate.
Measurement of DNA
DNA was quantified as previously described28 by fluorometry using bisbenzimide and calf thymus DNA as a standard. Fluorescence (Ex. 350 nm, Em. 450 nm) was measured with a Victor 1420 Multilabel Counter.
Measurement of Cell Proliferation
Bromodeoxyuridine (BrdU) incorporation was quantified by time-resolved fluorescence of a Europium chelate.29 Briefly, cells were labeled for 18 hours with BrdU (5 x 10-5 M). Thereafter, cell cultures were washed twice with TNT (0.1 Mol/L Tris-HCl, 0.15 Mol/L NaCl, 0.5% RIA grade albumin, pH 7.4), fixed using ethanol/acetic acid (95/5, v/v), and then incubated for 20 minutes at 4°C with 0.05 mol/L HCl. After another washing step, DNA was cleaved by incubation for 45 minutes at 80°C with formamide/trisodium citrate (88 mg trisodium citrate in 38 ml formamide). After 2 washing steps, nonspecific binding was blocked by incubation with FCS (diluted 1:1 with TNB: 0.1 mol/L Tris-HCl, 0.15 mol/L NaCl, 0.05% Tween 20, pH 7.4) followed by 3 washing steps. Thereafter, first antibody (mouse anti-BrdU IgG diluted 1:500 in TNB) was added and incubated with gentle shaking for 2 hours at 22°C. After 3 more washing steps, a second antibody (biotin-labeled anti-mouse IgG, diluted 1:500 in TNB) was added and incubated for another 60 minutes; thereafter DTPA (diethylentriaminepantaacetic acid, 20 µmol in TNB, pH 7.4) was added and incubated for 15 minutes at room temperature. After 3 additional washing steps, Europium-labeled streptavidin (diluted in TNB 1:1000) was added and incubated for 1 hour. After 5 washing steps, enhancement solution (150 µl/well) was added and incubated for 45 minutes at 22°C. Finally, time-resolved fluorescence of the europium-chelate was counted in a 100-µl aliquot using a Delfia Victor 1420 Multilabel Counter (Wallac).
RNA Isolation and Northern Blot
PSC cultures were stopped 10 hours after stimulation with macrophage supernatants to extract total RNA using the High Pure RNA Isolation Kit. For Northern blot analysis, 30 µg of total RNA was separated by gel electrophoresis in 1% agarose and 2.2 mol/L formaldehyde and transferred by capillary elution to Hybond-N membranes. Ethidium bromide staining of the agarose gels and hybridization with an 18S ribosomal RNA probe were used to verify equal loading and blotting of total RNA. Purified cDNA probes were labeled with [32P]dCTP. Prehybridizations (46 hours) and hybridizations (14 hours) were carried out in 6x standard saline citrate (1x SSC = 150 mmol/L NaCl, 15 mmol/L sodium citrate), 5x Denhardts reagent, 0.5% sodium dodecyl sulfate (SDS), 100 µg/ml yeast t-RNA, 50 µg/ml sonicated human placenta DNA, 10 µg/ml polyU-homopolymer, and 50% formamide at 42°C. The hybridization buffer was supplemented with 0.5 x 106 cpm/ml labeled cDNA. The membranes were washed several times with decreasing concentrations of SSC + 0.1% SDS, the final high stringency wash was done in 0.2x SSC. Exposure to X-ray films was done at -70°C for 7 to 10 days.
Statistics
Quantitative measurements of c-fibronectin, collagen type I, DNA, BrdU incorporation, and TGFß1 were done in duplicate. Results for fibronectin, DNA, and BrdU incorporation are presented as mean ± SD of at least three independent experiments. To measure collagen type I and TGFß1, two independent experiments were performed. Each condition in the different experiments was tested using three or six cultures (three or six wells). Analysis of variance was used to compare different data groups.
| Results |
|---|
|
|
|---|
Mononuclear cells were isolated from buffy coats, washed, counted,
resuspended in complete medium (5 x 106
cells/ml), and seeded in culture flasks, glass coverslips, and
petriPerm with a density of 6.6 x 104
cells/cm2. After 2 hours the nonadherent cells
were removed during a medium change. During the next 2 weeks in culture
monocytes differentiated to macrophages, showing characteristic
variations in morphology ranging from spindle-shaped cells to large
spread cells with many lamellipods (Figure 1A)
. Immunofluorescence staining (Figure 1B)
demonstrated that >95% of the monocyte-derived macrophages
expressed CD14 after 14 days in culture (Figure 1B)
. Furthermore,
during an incubation period of 6 hours, 50 to 70% of the cells showed
phagocytic activity toward fluorescein-labeled E. coli
(Figure 1B)
. Viability of cells which had been cultured for 2 weeks was
above 95%. Flow cytometric analysis of cells cultured for 10 to 14
days in petriPerm showed about 75% CD14-positive cells (2/3 weakly and
1/3 strongly positivity), 19% CD3-positive cells, and 2%
CD19-positive cells.
|
PSC that were isolated by density gradient centrifugation from rat
pancreas showed the fat-storing phenotype with numerous fat droplets
located in the perinuclear region of the cells (Figure 2A)
. Within 4 to 8 days in primary
culture, the number and the size of the fat droplets decreased, and the
cells developed long cytoplasmic extensions (Figure 2B)
and became
weakly positive for
-smooth muscle actin. After passage the fat
droplets almost completely disappeared and >90% of the cells
expressed
-smooth muscle actin (Figure 2C)
. The morphology of the
passaged cells was stellate-like with long cytoplasmic extensions or
spindle-shaped. Human PSC, which were obtained by outgrowth from small
tissue blocks of fibrotic pancreas, were mostly stellate-like (a few
were also spindle-shaped) without fat droplets in their cytoplasm.
Already in primary culture these cells expressed
-smooth muscle
actin and vimentin (data not shown).
|
To demonstrate paracrine stimulation of pancreatic stellate cell proliferation and matrix synthesis by soluble mediators produced by macrophages, macrophage-conditioned media were added to cultured human and rat PSC. The media had been conditioned for 24 hours by unstimulated and LPS-stimulated macrophages in the absence of FCS. Immunofluorescence staining of cell-associated collagen types I and III and fibronectin, Northern blot analyses of collagen type I and fibronectin, and quantitative immunoassay for collagen type I and c-fibronectin in cell culture supernatants were used to examine the effects of macrophage supernatants on ECM synthesis of PSC. The results obtained by the different methods were corresponding. In particular, transiently acidified media from LPS-activated macrophages significantly up-regulated ECM synthesis of cultured PSC.
To demonstrate the effects of macrophage supernatants on
cell-associated collagens and fibronectin, secondary cultured human PSC
grown on glass coverslips were incubated with 40 µl transiently
acidified macrophage supernatant per milliliter of medium for 38 hours.
Thereafter, cultures were fixed and immunostaining was performed. As
shown in Figure 3
, intensive staining
patterns of collagen type I (Figure 3C)
, collagen type III (Figure 3F)
,
and fibronectin (Figure 3I)
were observed in cultures receiving
supernatants of LPS-activated macrophages. Collagens were detected
predominantly intracellularly. Fibronectin was located predominantly
extracellularly as fibrils, varying in staining intensity and in
density. There was no significant difference in staining patterns
between untreated cells (Figure 3, A, D, and G)
and PSC incubated with
conditioned media of unstimulated macrophages (Figure 3, B, E, and H)
.
|
|
|
|
To demonstrate that TGFß1 represents the fibrogenic mediator produced by activated macrophages, TGFß1 concentration was measured in supernatants of unstimulated and LPS stimulated macrophages by time-resolved fluorescence immunoassay. As expected, LPS activated macrophages produced 3.4-fold more TGFß (6.61 pg/µg DNA) compared to unstimulated macrophages (1.97 pg/µg DNA) in 24 hours.
Effect of Macrophage Supernatants on PSC Proliferation
To investigate the effect of macrophage supernatants on proliferation of cultured PSC, BrdU incorporation was measured during a labeling period of 18 hours. In preceding experiments optimal BrdU concentration and labeling time had been determined. Incorporated BrdU was quantitated using time-resolved fluorescence immunoassay. To determine an inhibitory effect of macrophage supernatants on PSC, proliferation cells were cultured in the presence of 10% FCS and to determine a stimulatory effect PSC were cultured in the presence of 0.1% FCS. Neither native nor acidified supernatants of unstimulated and LPS-stimulated macrophages showed any inhibitory or stimulatory effect on PSC proliferation.
| Discussion |
|---|
|
|
|---|
Chronic pancreatitis is histologically characterized by infiltration of
leukocytes, duct alterations, and extended fibrosis.4
Leukocytes release cytokines and growth factors, eg, interleukin-1
(IL-1), IL-6, tumor necrosis factor
(TNF-
), and TGFß, which
are suggested to induce proliferation of mesenchymal cells and
accelerated deposition of the ECM.20,23,30-32
Emmerich at
al13
described a three- to fourfold increased number of
infiltrating macrophages in chronic pancreatitis and in pancreas
carcinoma. The paracrine role of macrophages during wound repair
in vivo has been demonstrated in studies that show that
fibrosis is suppressed if monocyte infiltration is
blocked.20
Activated macrophages release a number of
cytokines including TGFß,20
which is suggested to
represent one of the most prominent fibrogenic
mediators.33
In liver TGFß stimulates hepatic stellate
cell transformation30
and the synthesis of
collagens,31
proteoglycans,32
and
fibronectin.30
In early stages of pancreas fibrosis high
numbers of mononuclear cells staining positively for both pro-TGFß
and latent TGFß-binding protein (LTBP) were
demonstrated.27
TGFß is secreted by almost all cell
types in a latent, biologically inactive complex. One particular
function of LTBP is to target the latent TGFß complex to the cell
surface where activation occurs.34
Our data confirm earlier reports that activated (ie, LPS-treated) macrophages secrete TGFß.20 Macrophages activated by LPS secrete TGFß threefold compared to unstimulated cells. Interestingly, the TGFß1 mRNA steady state concentrations investigated by semiquantitative RT-PCR (data not shown) were similar in unstimulated compared to LPS-stimulated macrophages. These data are consistent with earlier reports on the regulation of TGFß gene expression and secretion of TGFß.20
Recently, we have shown on protein and mRNA level that serum stimulated
the synthesis of collagen types I and III and fibronectin in cultured
hPSC.11
It has been suggested that aggregating platelets
release the matrix synthesis-stimulating mediators. However, now we
present data demonstrating that macrophage supernatants, in particular
supernatants from LPS-activated macrophages, increased the steady-state
mRNA levels of fibronectin and collagen type I in cultured hPSC.
Furthermore, prominent staining patterns of collagen types I and III
and fibronectin were found intracellularly and extracellularly in hPSC
after stimulation with conditioned medium from LPS-activated
macrophages. Transient acidification of the macrophage supernatants
(before addition to cultured PSC) increased collagen type I and
fibronectin concentration in PSC supernatants compared to native
supernatants (see Figures 5 and 6
). This observation indicates that
TGFß might represent the responsible fibrogenic mediator in
macrophage supernatants. In experiments with PSC cultured in the
presence of 0.5% FCS (instead of 0.1% FCS) the stimulatory effect of
the macrophage supernatants on fibronectin synthesis was still
significant but less pronounced (1.7-fold versus threefold).
This result is in line with previous data demonstrating that among
several polypeptide growth factors present in serum (bFGF, PDGF,
insulin-like growth factors, TGBß, TNF
, TGF
) only
TGFß1 was able to stimulate fibronectin synthesis in the presence of
higher serum concentrations.11
The importance of TGFß in
experimental and human pancreas fibrogenesis is documented by several
studies.33
In rat cerulein pancreatitis TGFß1 gene
expression parallels collagen type I gene expression.10
Interestingly, TGFß1 protein increased earlier than TGFß mRNA in
pancreas tissue, suggesting that platelets might be the source of the
early TGFß1 protein increase.10
Thereafter TGFß1 is
released by inflammatory cells, stromal cells, and acinar
cells.10
To inhibit the TGFß effects during regeneration
from cerulein pancreatitis in rats, Menke et al35
injected
TGFß1-neutralizing antibodies and could show by this approach that
collagen types I and III protein and mRNA deceased significantly
compared to control (without anti-TGFß1). Furthermore, anti-TGFß1
inhibited the usually observed rise of the steady state levels of
TGFß1 mRNA and TGFß2 mRNA at the second day after cerulein
infusion,35
suggesting that the early TGFß1 release by
platelets induces the TGFß synthesis. In summary, the data obtained
in experimental models convincingly identified TGFß as the most
prominent fibrogenic mediator in pancreas.
In addition to the paracrine stimulation of ECM synthesis (eg, via TGFß), macrophages modulate matrix turnover by producing the 92-kd gelatinase matrix metalloproteinase-9 and the interstitial collagenase matrix metalloproteinase-1.36-38 Because TGFß reduces matrix metalloproteinase synthesis,39 net matrix accumulation is accelerated by an increased synthesis and a decreased matrix degradation.
In conclusion, our data indicate that activated macrophages might cooperate with pancreatic stellate cells in the development of pancreas fibrosis by secreting fibrogenic mediators (in particular TGFß), thus stimulating ECM synthesis in a paracrine way. Future studies will analyze the role of metalloproteinases in cell-cell interactions of PSC and inflammatory cells.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by Bausteinförderung University of Ulm (P.347) and Deutsche Forschungsgemeinschaft (SFB 518, Project A7) to M. G. B.
Accepted for publication July 15, 1999.
| References |
|---|
|
|
|---|
, granulocyte-macrophage CSF, and IL-1 ß through prostaglandin-dependent and -independent mechanisms. J Immunol 1998, 161:3071-3076This article has been cited by other articles:
![]() |
B. Reinhardt, M. Winkler, P. Schaarschmidt, R. Pretsch, S. Zhou, B. Vaida, A. Schmid-Kotsas, D. Michel, P. Walther, M. Bachem, et al. Human cytomegalovirus-induced reduction of extracellular matrix proteins in vascular smooth muscle cell cultures: a pathomechanism in vasculopathies? J. Gen. Virol., October 1, 2006; 87(Pt 10): 2849 - 2858. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sparmann, A. Glass, P. Brock, R. Jaster, D. Koczan, H.-J. Thiesen, S. Liebe, and J. Emmrich Inhibition of lymphocyte apoptosis by pancreatic stellate cells: impact of interleukin-15 Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G842 - G851. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. van Westerloo, S. Florquin, A. M. de Boer, J. Daalhuisen, A. F. de Vos, M. J. Bruno, and T. van der Poll Therapeutic Effects of Troglitazone in Experimental Chronic Pancreatitis in Mice Am. J. Pathol., March 1, 2005; 166(3): 721 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sparmann, C. Hohenadl, J. Tornoe, R. Jaster, B. Fitzner, D. Koczan, H.-J. Thiesen, A. Glass, D. Winder, S. Liebe, et al. Generation and characterization of immortalized rat pancreatic stellate cells Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G211 - G219. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Zimmermann, B Gloor, A Kappeler, W Uhl, H Friess, and M W Buchler Pancreatic stellate cells contribute to regeneration early after acute necrotising pancreatitis in humans Gut, October 1, 2002; 51(4): 574 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schneider, A. Schmid-Kotsas, J. Zhao, H. Weidenbach, R. M. Schmid, A. Menke, G. Adler, J. Waltenberger, A. Grunert, and M. G. Bachem Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells Am J Physiol Cell Physiol, August 1, 2001; 281(2): C532 - C543. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yoshikawa, Y. Kihara, M. Taguchi, T. Yamaguchi, H. Nakamura, and M. Otsuki Role of TGF-beta 1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats Am J Physiol Gastrointest Liver Physiol, March 1, 2002; 282(3): G549 - G558. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |